Cost analysis of cryotherapy for metastatic disease.

t w N n e t i a w t s m d t Bang and colleagues (1,2) have published their experience with percutaneous cryoablation for metastatic disease arising from non–small-cell lung carcinoma (NSCLC) (1) as well as renal cell carcinoma (2). In the first study (1), the authors describe results from 49 cryoablation procedures in 31 patients with metastatic NSCLC… CONTINUE READING